Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Ohki

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
The Journal of Biological Chemistry|August 10, 2000
Reprimo, a new candidate mediator of the p53-mediated cell cycle arrest at the G2 phaseR Ohki, J Nemoto, H Murasawa, et al.
Hypertension (Dallas, Tex. : 1979)|September 16, 2000
Fluvastatin inhibits matrix metalloproteinase-1 expression in human vascular endothelial cellsU Ikeda, M Shimpo, R Ohki, et al.
The American Journal of Cardiology|October 9, 2001
The site of mitral valve prolapse is a predictor of atrial fibrillationR Ohki, K Yamamoto, M Okayama, et al.
Oncogene|February 12, 2008
p53 target gene AEN is a nuclear exonuclease required for p53-dependent apoptosisT Kawase, H Ichikawa, T Ohta, et al.
Journal of Hypertension|November 18, 2000
Amlodipine increases nitric oxide synthesis in cytokine-stimulated cultured vascualar smooth muscle cellsU Ikeda, M Shimpo, R Ohki, et al.
Pacing and Clinical Electrophysiology : PACE|March 3, 2001
Torsades de pointes ventricular tachycardia induced by mosapride and flecainide in the presence of hypokalemiaR Ohki, M Takahashi, O Mizuno, et al.
Science (New York, N.Y.)|May 12, 2000
Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosisE Oda, R Ohki, H Murasawa, et al.
Genomics|June 15, 1997
The structure and organization of the human NPAT geneT Imai, T Sugawara, A Nishiyama, et al.
Journal of Neuro-Oncology|April 16, 1998
Expression of p53, MDM2 protein and Ki-67 antigen in recurrent meningiomasM Ohkoudo, H Sawa, M Hara, et al.
Leukemia|January 23, 2004
DNA microarray analysis of natural killer cell-type lymphoproliferative disease of granular lymphocytes with purified CD3-CD56+ fractionsY L Choi, H Makishima, J Ohashi, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
The Journal of Biological Chemistry|August 10, 2000
Reprimo, a new candidate mediator of the p53-mediated cell cycle arrest at the G2 phaseR Ohki, J Nemoto, H Murasawa, et al.
Hypertension (Dallas, Tex. : 1979)|September 16, 2000
Fluvastatin inhibits matrix metalloproteinase-1 expression in human vascular endothelial cellsU Ikeda, M Shimpo, R Ohki, et al.
The American Journal of Cardiology|October 9, 2001
The site of mitral valve prolapse is a predictor of atrial fibrillationR Ohki, K Yamamoto, M Okayama, et al.
Oncogene|February 12, 2008
p53 target gene AEN is a nuclear exonuclease required for p53-dependent apoptosisT Kawase, H Ichikawa, T Ohta, et al.
Journal of Hypertension|November 18, 2000
Amlodipine increases nitric oxide synthesis in cytokine-stimulated cultured vascualar smooth muscle cellsU Ikeda, M Shimpo, R Ohki, et al.
Pacing and Clinical Electrophysiology : PACE|March 3, 2001
Torsades de pointes ventricular tachycardia induced by mosapride and flecainide in the presence of hypokalemiaR Ohki, M Takahashi, O Mizuno, et al.
Science (New York, N.Y.)|May 12, 2000
Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosisE Oda, R Ohki, H Murasawa, et al.
Genomics|June 15, 1997
The structure and organization of the human NPAT geneT Imai, T Sugawara, A Nishiyama, et al.
Journal of Neuro-Oncology|April 16, 1998
Expression of p53, MDM2 protein and Ki-67 antigen in recurrent meningiomasM Ohkoudo, H Sawa, M Hara, et al.
Leukemia|January 23, 2004
DNA microarray analysis of natural killer cell-type lymphoproliferative disease of granular lymphocytes with purified CD3-CD56+ fractionsY L Choi, H Makishima, J Ohashi, et al.
Pageof 4